BIAN Guangliang, ZHANG Qian. Effect of oxiracetam on cognitive function of patients with cognitive dysfunction after stroke[J]. Journal of Clinical Medicine in Practice, 2020, 24(16): 29-31. DOI: 10.7619/jcmp.202016008
Citation: BIAN Guangliang, ZHANG Qian. Effect of oxiracetam on cognitive function of patients with cognitive dysfunction after stroke[J]. Journal of Clinical Medicine in Practice, 2020, 24(16): 29-31. DOI: 10.7619/jcmp.202016008

Effect of oxiracetam on cognitive function of patients with cognitive dysfunction after stroke

More Information
  • Received Date: June 18, 2020
  • Available Online: September 14, 2020
  • Objective To investigate the effect of oxiracetam on cognitive function of patients with cognition dysfunction after stroke. Methods Totally 87 patients with cognition dysfunction after stroke were divided into control group(n=43)and observation group(n=44)according to blind selection method. The control group was treated with piracetam, and the observation group was treated with oxiracetam. The clinical efficacy, cognitive function, levels of cytokines and the incidence of adverse reactions were compared between two groups. Results The total effective rate of the control group was 79.07%, which was significantly lower than 95.45% of the observation group(P<0.05). After treatment, the scores of Mini-mental State Examination(MMSE)in both groups were significantly higher than those before treatment, and the score of MMSE in the observation group was significantly higher than that in the control group(P<0.05). After treatment, the levels of matrix metalloproteinase-3(MMP-3)and malondialdehyde(MDA)in both groups were significantly lower than those before treatment, the level of superoxide dismutase(SOD)was significantly higher than that before treatment, the levels of MMP-3 and MDA in the observation group were significantly lower than those in the control group, and the level of SOD in the observation group was significantly higher than that in the control group(P<0.05). The incidence of adverse reactions in the observation group was 6.82%, which showed no significant difference when compared to 13.95% in the control group(P>0.05). Conclusion Oxiracetam is effective in the treatment of patients with cognitive dysfunction after stroke, which can effectively improve the cytokines level and cognitive function and it has a higher safety.
  • 孙金菊, 陈长香, 张敏, 等. 言语听觉反馈训练对脑卒中患者认知功能障碍的康复效果[J]. 中华行为医学与脑科学杂志, 2017, 26(6): 524-528.
    邵培宁, 秦荣荣, 尹彩霞, 等. 奥拉西坦治疗急性脑梗死认知功能的疗效[J]. 江苏医药, 2016, 42(19): 2174-2175.
    WANG J, HU Z, YANG S, et al. Inflammatory cytokines and cells are potential markers for patients with cerebral apoplexy in intensive care unit[J]. Exp Ther Med, 2018, 16(2): 1014-1020.
    中华医学会神经病分会脑血管病组. 中国急性缺血性脑卒中诊治指南[J]. 中华神经科杂志, 2010, 43(2): 2-3.
    纪裕伟, 杨晓飞, 郭金礼, 等. 组织化卒中医疗对脑卒中患者NIHSS、GCS和ADL评分的影响及疗效研究[J]. 河北医药, 2019, 41(12): 1817-1820.
    储新娟, 涂志兰, 金芃芃, 等. 缺血性脑卒中患者血管性认知功能障碍的现状及影响因素分析[J]. 中国临床医生杂志, 2017, 45(12): 43-44.
    RONG Y, FENG S, WU C, et al. LC-high-resolution-MS/MS analysis of chemical compounds in rat plasma after oral administration of Nao-Mai-Tong and its individual herbs[J]. Biomed Chromatogr, 2017, 31(7): 156-158.
    何培成, 许著一. 血清同型半胱氨酸、维生素B12水平对急性缺血性脑卒中患者认知功能及预后的影响[J]. 实用临床医药, 2019, 23(24): 27-30.
    雷敏, 吴丽荣, 刘英. 丁苯酞对脑卒中后抑郁患者血清同型半胱氨酸、神经细胞因子、单胺类递质和炎症因子的影响研究[J]. 陕西医学杂志, 2019, 48(7): 853-855.
    吴红霞, 韩天明, 欧小凡, 等. 血清Th细胞因子在脑卒中后抑郁患者血清中的表达水平分析[J]. 临床和实验医学杂志, 2019, 18(17): 1841-1844.
    FAN W, LI X, HUANG L, et al. S-oxiracetam ameliorates ischemic stroke induced neuronal apoptosis through up-regulating α7 nAChR and PI3K/Akt/GSK3β signal pathway in rats[J]. Neurochem Int, 2018, 115(7): 50-60.
    王翔, 张铭, 唐卫华. 瓜蒌承气汤加减联合奥拉西坦治疗急性脑出血的临床研究[J]. 中西医结合心脑血管病杂志, 2019, 17(13): 1947-1950.
  • Related Articles

    [1]LIU Kun, XU Qingyi, ZHU Jun, CHEN Fang. A comparison of macular morphology and microcirculation index in patients with pathological myopic choroidal neovascularization at different ages[J]. Journal of Clinical Medicine in Practice, 2023, 27(18): 65-69. DOI: 10.7619/jcmp.20231883
    [2]REN Yizhou, LIU Xiaorong, LI Zhe, XU Min, CHEN Fang, GAN Chunlan. Quantitative study of vessel density in optic disc and macular region in patients with nonarteritic anterior ischemic optic neuropathy[J]. Journal of Clinical Medicine in Practice, 2023, 27(4): 70-75, 79. DOI: 10.7619/jcmp.20222588
    [3]SHEN Yongzhi, HUANG Jiali, XIAN Kegong, LI Zhihui, ZHAO Fentu. Application of optical coherence tomography angiography in fundus screening in newly diagnosed patients with type 2 diabetes[J]. Journal of Clinical Medicine in Practice, 2023, 27(4): 56-60. DOI: 10.7619/jcmp.20222539
    [4]WU Huihui, ZHANG Xue, WANG Yan, LIU Yan, LUO Na, CHEN Fang. Quantitative study of optic disc blood flow density and thickness of peripapillary retinal nerve fiber layer in patients with diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2022, 26(7): 57-61. DOI: 10.7619/jcmp.20213748
    [5]ZHOU Chunshan, HUANG Yan, YAN Wenchao. Value of computed tomography scan versus magnetic resonance imaging in the diagnosis of pancreatic cystadenocarcinoma[J]. Journal of Clinical Medicine in Practice, 2020, 24(20): 47-50. DOI: 10.7619/jcmp.202020013
    [6]ZHAO Chenghua. Value of artificial intelligence assisted diagnostic system combined with CT test in diagnosis of pulmonary nodules[J]. Journal of Clinical Medicine in Practice, 2020, 24(19): 9-11. DOI: 10.7619/jcmp.202019003
    [7]LU Cuihong, ZHANG Baoyuan. Brain computed tomography findings and their diagnostic value in elderly patients with cerebral hemorrhage[J]. Journal of Clinical Medicine in Practice, 2019, 23(24): 8-10. DOI: 10.7619/jcmp.201924003
    [8]GONG Yujing, WU Binghui, SUO Yan, LU Huiqin, QU Xiaoyu. Characteristics of choroidal neovascularization in optical coherence tomography angiography versus fluorescein angiography[J]. Journal of Clinical Medicine in Practice, 2019, 23(22): 14-16. DOI: 10.7619/jcmp.201922005
    [9]TIAN Juan, WANG Huifang, DONG Jianghua. Value of abdominal computed tomography in evaluating extramural vascular invasion of gastric cancer[J]. Journal of Clinical Medicine in Practice, 2019, 23(7): 29-31, 36. DOI: 10.7619/jcmp.201907008
    [10]JIANG Hongfen, GU Jie, XU Yanling, MENG Haoyu, ZHANG Dingguo, JIA Enzhi, CHEN Leilei, WANG Liansheng, SHI Dongmei. Perioperative nursing of new generation optical coherence tomography in diagnosis of percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2018, (12): 4-7. DOI: 10.7619/jcmp.201812002
  • Cited by

    Periodical cited type(15)

    1. 薛彦霞,刘雨情,续自凤. 升降散加减治疗重症肺炎(痰热壅肺型)的效果及对炎症因子和外周血T淋巴细胞群的影响. 中外医疗. 2024(09): 31-34 .
    2. 张敏. 中医定向透药疗法对肺炎患儿临床疗效及炎性因子水平的影响. 反射疗法与康复医学. 2024(17): 8-10+17 .
    3. 李文艳,许志强. 呼吸机相关肺炎危重症患者使用合生元制剂联合肠内营养序贯治疗的临床研究. 中国药物与临床. 2024(20): 1341-1345 .
    4. 闵翼,殷智,潘旭. 清金降火汤治疗痰热壅肺型肺炎的临床研究. 航空航天医学杂志. 2023(01): 66-68 .
    5. 李思灵,颜沃志,廖夏萍. 纤维支气管镜下盐酸氨溴索注射液肺泡灌洗治疗COPD合并呼吸衰竭的效果. 中国医学创新. 2023(02): 50-54 .
    6. 郑相,范青红,邱芳晖. 清肺化痰汤联合西医常规治疗呼吸机相关性肺炎老年患者临床研究. 新中医. 2023(04): 21-24 .
    7. 董璐阳,张琳,李怡辉. 中医护理干预对呼吸机相关肺炎患者血气指标、生活质量的影响. 实用中医内科杂志. 2023(02): 80-83 .
    8. 丁鑫,钱占红. 升降散对脓毒症所致急性肺损伤小鼠的保护作用. 环球中医药. 2023(04): 591-597 .
    9. 罗志辉,王昆秀,张艳琳,陈子琴,陈贝,陈佳,周婷,顾骁磊,李崇立,闫鹏,田玲玲,徐驰成,陈柏霖,陈松,祁青. 回顾性分析三消饮加减方治疗轻型/普通型新型冠状病毒肺炎患者的临床疗效. 中国实验方剂学杂志. 2022(01): 150-156 .
    10. 周同鑫,石静娟,裴昶,曹振华,殷智,钱丽. “支炎一号”方治疗成人痰热壅肺型支气管扩张临床疗效分析. 中外医疗. 2022(02): 103-106 .
    11. 章文莉,汪芬华,陈梅. 天枢穴贴敷联合升降散保留灌肠治疗呼吸机相关性肺炎52例. 中国中医药科技. 2022(05): 931-932+935 .
    12. 马文静,张维利,刘素梅,祁佩红. 加味温胆汤对痰湿蕴肺型慢性阻塞性肺疾病急性加重期患者炎症细胞因子表达及BODE指数的影响. 中医药信息. 2022(09): 53-57+62 .
    13. 姜立娟,魏岩,张文风. 升降散证治探微. 长春中医药大学学报. 2022(10): 1063-1066 .
    14. 张爱宝,白小丽,成媛,薛云霞. 超声脉冲电导辅助治疗小儿支气管肺炎的临床观察. 中国民间疗法. 2021(15): 77-79 .
    15. 刘蓉. 心外科ICU呼吸机相关性肺炎患者病原菌的分布分析与研究. 名医. 2020(10): 85-86 .

    Other cited types(2)

Catalog

    Article views (460) PDF downloads (14) Cited by(17)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return